AO-176 in Multiple Solid Tumor Malignancies
NCT03834948
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
57
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Interventions
DRUG:
AO-176
DRUG:
AO-176 + Paclitaxel
DRUG:
AO-176 + Pembrolizumab
Sponsor
Arch Oncology
Collaborators
[object Object]